Topische EGF-Applikation bei therapierefraktärer Erosio corneae unter Cetuximab-Behandlung
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/content/pdf/10.1007/s00347-007-1527-8.pdf
Reference6 articles.
1. Cunningham D, Humblet Y, Siena S et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351: 337–345
2. Liu Z, Carvajal M, Carraway CA et al. (2001) Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2 and ErbB3 in human ocular surface epithelia. Cornea 20: 81–85
3. Nahamura Y, Sotozono C, Kinoshita S (2001) The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res 72: 511–517
4. Vallbohmer D, Lenz HJ (2005) Epidermal growth factor receptor as a target for chemotherapy. Clin Colorectal Cancer (Suppl 1) 5: S19–S27
5. Vicenzi B, Santini D, Rabitti C et al. (2006) Cetuximab and irinotecan as third-line therapy in andvanced colorectal cancer patients: a single centre phase II trial. Br J Cancer 94: 792–797
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress on the application of growth factor-related drugs in ophthalmology;Journal of Zhejiang University (Medical Sciences);2022-10-01
2. Superficial Punctate Keratoepitheliopathy Under Treatment with Erlotinib and Lapatinib;Journal of the Korean Ophthalmological Society;2014
3. Posology, Efficacy, and Safety of Epidermal Growth Factor Eye Drops in 305 Patients: Logistic Regression and Group-Wise Odds of Published Data;Journal of Ocular Pharmacology and Therapeutics;2012-10
4. The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?;Acta Ophthalmologica;2012-09-12
5. Ocular Adverse Events of Systemic Inhibitors of the Epidermal Growth Factor Receptor: Report of 5 Cases;Ophthalmology;2012-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3